Literature DB >> 11576058

Probability of acceptable intubation conditions with low dose rocuronium during light sevoflurane anaesthesia in children.

M Eikermann1, K Renzing-Köhler, J Peters.   

Abstract

BACKGROUND: To define the rocuronium doses which would provide 50%, 90%, and 95% probability of 'acceptable' intubation conditions during light sevoflurane anaesthesia, we studied 60 children aged 2-7 years in a prospective, randomised, assessor blinded study.
METHODS: After mask ventilation with 1 MAC sevoflurane/N2O for 17+/-1 (x+/-SD) min we administered rocuronium (either 0.15, 0.22, 0.3, 0.5, or 1.0 mg. kg(-1)) or placebo, and quantified the evoked force of the adductor pollicis muscle. Intubation conditions were assessed before and 2 min after injection of the test drug.
RESULTS: Intubation conditions were improved significantly with rocuronium and scored 'acceptable' in 70%, 90%, and 100% of the children after injection of rocuronium 0.15, 0.22, and 0.3 mg x kg(-1), respectively. In parallel, twitch tension decreased to 53% (6-100), 26% (11-100), and 11% (0-19) of baseline (median (range)). Recovery of train-of-four ratio to 0.8 was achieved 13 (7-19), 16 (8-28), and 27 (23-44) min after injection of the respective rocuronium doses. Higher rocuronium doses did not further improve intubation conditions but only prolonged time of neuromuscular recovery. Logistic regression analysis revealed that rocuronium 0.11 (CI 0.05-0.16), 0.21 (0.14-0.28), and 0.25 (0.15-0.34) mg x kg(-1) provides a 50%, 90%, and 95% probability of 'acceptable' intubation conditions in children during 1 MAC sevoflurane/N2O anaesthesia, respectively. Furthermore, we calculated that force depression of adductor pollicis muscle to 81% (CI 72-90), 58% (42-74), and 50% (29-71) of baseline is associated with 50%, 90%, and 95% probability of 'acceptable' intubation conditions.
CONCLUSIONS: Submaximal depression of muscle force with low dose rocuronium improves intubation conditions in children during light sevoflurane anaesthesia while allowing rapid recovery of neuromuscular function. However, when using low dose rocuronium neuromuscular monitoring may be helpful to detect children with inadequate response to the relaxant so as to avoid an unsuccessful intubation attempt.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576058     DOI: 10.1034/j.1399-6576.2001.450819.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  The effect of alfentanil versus ketamine on the intubation condition and hemodynamics with low-dose rocuronium in children.

Authors:  Ji Young Kim; Jong Seok Lee; Hee Yeon Park; Yong Beom Kim; Youngjun Kwon; Hyun Jeong Kwak
Journal:  J Anesth       Date:  2012-09-22       Impact factor: 2.078

2.  Intubation time required for tracheal intubation with low-dose rocuronium in children with and without atropine.

Authors:  Hyun Jeong Kwak; Sang Kee Min; Bong Ki Moon; Kyung Cheon Lee; Yong Beom Kim; Jong Yeop Kim
Journal:  J Anesth       Date:  2012-09-16       Impact factor: 2.078

3.  Appropriate sevoflurane concentration to stabilize autonomic activity during intubation with rocuronium in infants: a randomized controlled trial.

Authors:  Hiroshi Hanamoto; Aiji Boku; Yoshinari Morimoto; Mitsutaka Sugimura; Chiho Kudo; Hitoshi Niwa
Journal:  BMC Anesthesiol       Date:  2015-04-29       Impact factor: 2.217

4.  All India Difficult Airway Association 2016 guidelines for the management of unanticipated difficult tracheal intubation in Paediatrics.

Authors:  Dilip K Pawar; Jeson Rajan Doctor; Ubaradka S Raveendra; Singaravelu Ramesh; Sumalatha Radhakrishna Shetty; Jigeeshu Vasishtha Divatia; Sheila Nainan Myatra; Amit Shah; Rakesh Garg; Pankaj Kundra; Apeksh Patwa; Syed Moied Ahmed; Sabyasachi Das; Venkateswaran Ramkumar
Journal:  Indian J Anaesth       Date:  2016-12

5.  Subparalyzing Doses of Rocuronium Reduce Muscular Endurance without Detectable Effect on Single Twitch Height in Awake Subjects.

Authors:  Jan Gelberg; Peter Bentzer; David Grubb
Journal:  Anesthesiol Res Pract       Date:  2019-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.